Displaying 37 - 54 of 143
The Truth About Black Men's Health: Your Time to Talk, Our Time to Listen
June is Men's Health Month. In recognition, the Men's Health Council of Durham County and Duke Cancer Institute Office of Health Equity are collaborating to host "The Truth About Black Men's Health: Your Time to Talk, Our Time to Listen." This forum will address health issues relevant to men in our...
Man Dedicates Life To Moving Research Further
The beeping monitor disrupts the stillness that fills Roger Bryant’s hospital room. Beth, his wife of 23 years, gently caresses his head as she shares stories of his life with the nurse adjusting his pain medication. Every now and then, Roger faintly smiles at something Beth mumbles, silently...
Blurring The Racial Lines On Prostate Cancer
An increased survival benefit for African-American men with advanced prostate cancer and a stronger response to hormone therapy were the centerpieces of key racial disparity studies presented by researchers from Duke’s Prostate & Urologic Cancer Center at the 2018 American Society of Clinical...
Researchers Identify Promising New Drug Target for Lethal Prostate Cancer
Targeting a protein genome-binding process that directs expression of diverse cancerous genes could be an important new therapy approach for stopping the progression of late-stage prostate cancer, according to Duke researchers. The study , published Tuesday, May 29, 2018 in the journal Proceedings...
Cycle Coach Inspires Through Personal Cancer Ride
It’s Monday afternoon at the UNC Rex Wellness Center gym and cycling class participants begin to find their way into the bike saddles, readying themselves to push the pedals for the next 45 minutes. The lights dim as Rick Leavitt, 71, finishes lacing up his shoes to lead the ride ahead. It’s go-...
Tests Identify When Advanced Prostate Cancer Therapies Would Benefit
Two blood tests can predict which subset of men with advanced prostate cancer will likely not benefit from anti-androgen therapies, providing doctors and patient added clarity on treatment options, according to a study led by Duke Cancer Institute . The blood tests, dubbed “liquid biopsies”, detect...
Black Patients Show Stronger Response to Hormone Therapy for Prostate Cancer
African-American men with advanced prostate cancer might be more responsive than white men to an anti-androgen drug and steroids, according to a study led by Duke Cancer Institute researchers. While median survival was similar for both black and white participants in the study, the findings...
Analysis: Survival Benefit for African-Americans with Advanced Prostate Cancer
Contrary to current perceptions, certain African-American men with advanced prostate cancer have as good a chance of survival as white men and might actually have a small advantage, according to a new analysis of more than 8,000 patients who participated in clinical trials. In a study presented...
Smell Receptor Fuels Prostate Cancer Progression
When scientists first described the receptors responsible for our sense of smell, they naturally assumed that these chemical sensors resided exclusively in the lining of our noses. But then olfactory receptors started turning up in the strangest places -- the lungs, liver, skin, heart, testes and...
Our Journey with Prostate Cancer
I met Donald “Don” Ward in the spring of 1994 in a Sacred Harp singing group in Palo Alto, California. Over time, we struck up an acquaintance and started dating, and from our first date, we were perfect together. On our early outings, we hiked in the coastal hills between Palo Alto and the Pacific...
Bone Scan Software Accurately Calculates Prognosis of Advanced Prostate Cancer
A software tool to automatically calculate how extensively bones have been infiltrated by prostate cancer is both accurate and speedy, capturing key prognostic information related to survival and the development of symptoms over time. The software, called the automated bone scan index, was tested...
Utah Cancer Expert Named Chair Of Department of Medicine
Kathleen Cooney, MD, a medical oncologist and internationally known physician scientist, has been named chair of the Department of Medicine at Duke University School of Medicine. Cooney joins Duke from the University of Utah School of Medicine, where she is the H.A. and Edna Benning Presidential...
New Advances in Overcoming Prostate Cancer Disparities
African American men are nearly two times more likely to develop prostate cancer than white men and nearly three times more likely to die from the disease. In North Carolina, the rate of prostate cancer-related deaths among African Americans is higher than the national average. Researchers at the...
Free Prostate Cancer Screening (9.8 and 9.9.18)
Men between the ages of 45‐75 who have never been diagnosed with prostate cancer, are invited to come and get a free onsite prostate cancer screening; including prostate specific antigen (PSA) and digital rectal exam (DRE), at the locations and times listed below. Free blood pressure exams,...
Gospel Singer Gives Hereditary Cancer Diagnosis A Different Tune
Every Sunday, you can find Marisha Hargrove, 28, at the front of her hometown church leading the congregation in worship with gospel songs. Marisha’s voice is strong and powerful as she belts out her favorite song “I Don’t Know About Tomorrow,” bringing churchgoers to its feet. The ballad’s lyrics...
Aptamers May Form New, Safer Chemotherapy Delivery Systems
Using chemotherapy along with aptamers—lab-made molecules that function like antibodies—Duke Health researchers showed that they can zero in on and kill prostate cancer tumors in mice while leaving healthy tissue unscathed. The finding suggests that aptamers could form the basis of new cancer...